Omada Health prices IPO at $19 per share, in middle of expected range

Omada Health priced its IPO at $19 per share on Thursday, in the middle of the expected range. The virtual chronic care company said in a press release that 7.9 million shares are being sold in the offering, amounting to $150 million. Omada, founded in 2012, will trade on the Nasdaq under the ticker symbol "OMDA." The company filed its initial prospectus in May and updated the document with an expected pricing range of $18 to $20 per share. At the IPO price, Omada is worth about $1.1 billion, though that number could be higher on a fully diluted basis. That's right around its private market valuation from 2022, when Omada announced a $192 million funding round that pushed its valuation above $1 billion. U.S. Venture Partners, Andreessen Horowitz and Fidelity's FMR LLC are the largest outside shareholders in the company, each owning between 9% and 10% of the stock. Omada offers virtual care programs to support patients with chronic conditions like prediabetes, diabetes and hyperten ... Read full article.